Groundbreaking Achievement: Human Receives First Ever Genetically Edited Pig Kidney Transplant

In the scenic town of Weymouth, 62-year-old Richard (Rick) Slayman underwent a four-hour surgery on March 16th, receiving a kidney. He has been battling type 2 diabetes and high blood pressure, common causes of chronic kidney disease.

Slayman had previously received a human kidney transplant, but signs of failure appeared five years later, leading him back to dialysis and regular hospital visits to manage dialysis complications.

“A testament to years of dedication from countless scientists and physicians, this transplant marks a truly unique achievement.” We are fortunate to play a significant role in this milestone,” said Professor and Director Tatsuo Kawai of the Massachusetts General Hospital’s Center for Clinical Transplant Tolerance, who led the transplant team and performed Slayman’s first kidney transplant in 2018.

“With a unique transplant perspective, we aim to be a lifeline for millions worldwide battling kidney failure,” he added.

Addressing a crucial need

Researchers are exploring the transplantation of organs or tissues from other animals, known as xenotransplantation, as a solution to the shortage of donated organs worldwide. Recently, transplanting pig hearts into living patients and pig kidneys into brain-dead recipients has gained attention.

According to the United Network for Organ Sharing, over 100,000 people in the US are awaiting organ transplants, and 17 people die each day waiting for one. Literature published in the Journal of the American Society of Nephrology indicates that kidneys are the most needed organs.

Of the estimated 36 million Americans affected by chronic kidney disease, nearly 800,000 suffer from end-stage kidney disease or kidney failure, a terminal condition requiring either a new kidney or prolonged, painful dialysis sessions that filter waste from the blood multiple times a week, sometimes for hours at a time.

Transplanting organs safely from animals to humans requires several stages to reduce the risk of rejection by the recipient’s immune system – a concern with human organ transplants as well – and to prevent infections and other complications.

“Attempts at pig xenotransplantation have faced obstacles. The good news is we are capable of overcoming those obstacles,” said Professor Joren Madsen, the Paul S. Russell/Warner-Lambert Professor of Surgery at HMS and director of the MGHTC.

“If simplicity ruled, we’d have mastered it. But the challenge persists, beckoning us to rise above. Pig xenotransplantation presents unique challenges. The good news is we are capable of overcoming those challenges.”

Scientific Advancement

In the initial phase, genetic modification was involved in making pig organs more compatible with humans. The kidneys used in the new surgery were modified using CRISPR-Cas9 gene editing technology:

Some genes in pigs were removed that produce sugar with antibodies, which trigger our immune system response.

To improve kidney compatibility with humans, some human genes were added.

To eliminate the risk of infection in recipients, all viral elements present in the pig genome were deactivated, known as porcine endogenous retroviruses.

In total, there were 69 genomic edits in the kidney.

The modified kidneys were provided by Genesis, a xenotransplantation therapy company co-founded by HMS geneticist George Church and former HMS postdoctoral fellow Luhán Yang. Over the past five years, Mass General and Genesis have conducted extensive research, the results of which were published in Nature in October 2023. Patients also received new monoclonal antibody drugs designed specifically to suppress immune responses against pig tissues.

Medications were made available by two pharmaceutical companies at no cost.

Leonardo Riella, associate professor and medical director of transplantation surgery at HMS Herald and Ellen Danser Surgery, said, “This collaborative nature of education and industry is crucial for progress, which we are sharing today.”

Animals and resistant drugs were extensively tested in animal models to ensure that the team has developed an optimal protocol for application in humans.

Kidney “Turned Pink Immediately”

As soon as the surgical team—led by Real, Kawai, and Nahel Elias, assistant professor of surgery at HMS, interim chief of transplant surgery, and surgical director of kidney transplantation at Mass General—completed the kidney attachment, the new organ “turned pink immediately,” said HMS associate professor of medicine and nephrologist at Mass General, Winfred Williams.

He said, “It caught the urine and was producing urine.” “Applause broke out. It was quite a remarkable experience.”

According to the Mass General team, about a week after surgery, the patient, Mr. Sleman, is recovering well and is expected to be discharged soon.

Madison said, “Today the real hero is patient Mr. Sleman because without his courage and willingness to embark on this groundbreaking surgery, once considered unimaginable, the journey into the unknown in the medical field would not have been possible.”

Vigilant Optimism

The long-term implications of transplantation are still unclear.

“There are many unknowns,” said Riela. “This is the first time we’re doing something like this.”

According to General Maas F.A.Q., if the slum man doesn’t need to return to dialysis, the surgery will be considered successful. The team hopes that the pig’s kidney will improve the slum man’s health, perhaps buying him more time to acquire another donated human kidney.

“Kawai’s kidney longevity remains a mystery, but with a dash of optimism, he’s eyeing a distinctive two-year milestone, driven by intriguing preclinical discoveries.”

The slum man was approved for experimental procedures under the Expanded Access Protocol or EAP, often referred to as the compassionate use protocol. These are granted to groups of seriously ill or terminal patients when there are no comparable treatment options available.

Riela led the team in applying for EAP. FDA rigorously reviewed it before issuing approval at the end of February.

Understanding the efficacy of Porcine Kidney Transplantation requires not only more time but also more patience.

Williams emphasized the compassionate approach, describing it as a single-patient study. However, he stressed the importance of transitioning to a broader clinical trial for safety and effectiveness validation.

For instance, it might reveal that optimal results for pig organs require even more genetic editing.

Currently, there’s growing hope for kidney xenotransplantation to one day save lives and improve the quality of life by reducing the need for kidney dialysis.

“We hope dialysis will become obsolete,” said Riela. “We firmly believe xenotransplantation presents a viable option either as a bridge to human kidney transplantation or as a permanent solution in the future.”

He added, “In the MGCH alone, there are over 1,400 patients on the waiting list for kidney transplantation.” “Some of these patients may unfortunately die or become too ill for transplantation due to prolonged waits for dialysis. I’m confident xenotransplantation offers a promising solution to the crisis of organ shortage.”

Health Disparities

The team also aims to mitigate health disparities associated with xenotransplantation failure and transplantation. 

Williams stressed, “Persistent racial gaps in kidney transplant access pose a significant challenge despite prior nationwide initiatives.” Let’s delve deeper into addressing this unique healthcare disparity.

He added, “The abundant supply of organs resulting from this technical advancement can ultimately help achieve health equity and provide the best solution for end-stage kidney failure – a well-functioning kidney – to all deserving patients.”

Williams commended the bravery of the slum man, who is Black, “for pioneering in the field of transplantation.”

When Williams and the transplant team proposed pig kidney transplantation to a man from the slums, detailing the procedure’s advantages and risks. They saw it not just as a personal aid but as a beacon of hope for many. “Transplantation for survival,” the slum man said in a statement.

Cost is another factor. Williams said the expense associated with slum man’s transplantation, as a first-of-its-kind procedure, is “substantial,” making it prohibitive for most patients; however, if the surgery becomes routine, the cost should decrease, he said.

History of Success:

General Mass Brigham’s history with organ transplantation is rich in innovation. Brigham and Women’s Hospital surgeons performed the first successful human organ transplantation – a kidney also – in 1954. Today’s MGCH transplant physicians and surgeons bring nearly 30 years of combined experience in xenotransplantation research.

Elias said the slum man’s team included physicians, surgeons, scientists, anesthesiologists, and nurses.

“Our physicians, researchers, and scientists are tirelessly committed to improving the lives of our transplant patients – present and future – and this dedication is at the heart and soul of academic medicine’s meaning and purpose,” said David F.M. Brown, Chair of Academic Medicine Centers at MGCH.

“We are immensely grateful to our hospital’s dedicated staff who aided in making this surgery successful and thank the patient for his bravery and courage,” he said.

• 
  Travel Experts Rank the Top Packing Cubes for Seamless Adventures
• 
  New Study Finds Intensive Weekend Workouts Key to Shedding Belly Fat
• 
  What exactly is Dropshipping? A Deep Dive into the E-commerce Phenomenon
• 
  Optimizing Supply Chain Management with Predictive Analytics: A Game-Changer for Businesses
• 
  OpenAI Introduces Groundbreaking Audio Feature: Text-to-Speech Capability Mirrors Human Voices